The U.S. Drug Enforcement Administration is continuing its efforts to gain regulatory control of so-called “designer drugs” that mimic the effects of other illicit drugs and have been blamed for overdoses, hospitalizations and deaths among youth who use them. These substances principally are of three classes: phenethylamine substances, synthetic cathinones and synthetic cannabinoi... Read More